Tenax Therapeutics (TENX) Research & Development (2016)
Historic Research & Development for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to $6.7 million.
- Tenax Therapeutics' Research & Development changed N/A to $6.7 million in Q4 2016 from the same period last year, while for Dec 2016 it was $15.7 million, marking a year-over-year change of. This contributed to the annual value of $12.7 million for FY2024, which is 29358.93% up from last year.
- According to the latest figures from Q4 2016, Tenax Therapeutics' Research & Development is $6.7 million.
- In the past 5 years, Tenax Therapeutics' Research & Development registered a high of $24.5 million during Q2 2013, and its lowest value of $369447.0 during Q1 2013.
- For the 4-year period, Tenax Therapeutics' Research & Development averaged around $6.5 million, with its median value being $2.8 million (2015).
- Its Research & Development has fluctuated over the past 5 years, first soared by 464431.81% in 2012, then plummeted by 3841.88% in 2013.
- Quarter analysis of 4 years shows Tenax Therapeutics' Research & Development stood at $604574.0 in 2012, then surged by 3957.59% to $24.5 million in 2013, then crashed by 90.14% to $2.4 million in 2015, then soared by 175.0% to $6.7 million in 2016.
- Its Research & Development stands at $6.7 million for Q4 2016, versus $3.2 million for Q3 2016 and $3.4 million for Q2 2016.